Bryan Morton has an MBA and BSc in Pharmacology. He began his pharmaceutical career in sales and has held positions in medical information, marketing, sales management, business development and general management during a 30 year career largely with Merck and Co. Inc. and Bristol Myers Squibb. He has lived and worked in UK, USA, Australia and Belgium and in 2003 founded Zeneus Pharma through the acquisition of Elan's European sales and marketing business. Backed by Apax, this venture resulted in the sale of Zeneus to Cephalon in late 2005 after two highly successful years of profitable operation. He is a Non-executive Director of biopharmaceutical company, Protherics Plc, and President of EUSA Pharma.
-v2.jpg "Bryan Morton - Non Executive Director")